PLX Technology, Inc. (NASDAQ:PLXT) today announced the appointment of semiconductor industry veteran Ralph Schmitt as president and chief executive ...

PLx Pharma Inc. Submits Supplemental New Drug Applications for VAZALORE™ 325 mg and 81 mg to U.S. Food and Drug Administration PRESS RELEASE GlobeNewswire Nov. 16, 2020, 04:01 PM ...

The PLX SuperSpeed USB portfolio now includes two PCIe Gen2-to-USB 3.0 peripheral controller/bridge devices and several SATA-to-USB 3.0 direct attached storage devices. Visit PLX at booth #512.

Houston-based PLx Pharma Inc. on Monday filed for an initial public offering, seeking to sell up to $20 million worth of shares. The specialty pharmaceutical company focuses on delivery systems ...

Other risks and uncertainties are more fully described in PLx’s prospectus supplement filed with the SEC on June 12, 2017, and in other filings that PLx will make going forward.

PLX Technology, Inc. , a leading global supplier of high-speed connectivity solutions enabling emerging data center architectures, today announced that the PLX® Board of Directors has appointed ...

The PLX-PAD comprehensive clinical development plan has been recognized by both the EMA and FDA, targeting a sub-population of 20 million patients in the Peripheral Artery Disease (PAD) market.